Inspire Investing LLC Trims Stock Holdings in Maximus, Inc. $MMS

Inspire Investing LLC lowered its position in shares of Maximus, Inc. (NYSE:MMS) by 72.3% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 4,919 shares of the health services provider’s stock after selling 12,832 shares during the period. Inspire Investing LLC’s holdings in Maximus were worth $449,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MMS. Canada Pension Plan Investment Board bought a new position in shares of Maximus in the 2nd quarter worth about $35,000. UMB Bank n.a. grew its holdings in Maximus by 37.5% in the second quarter. UMB Bank n.a. now owns 833 shares of the health services provider’s stock worth $58,000 after purchasing an additional 227 shares during the period. Bayforest Capital Ltd bought a new position in shares of Maximus during the second quarter valued at approximately $61,000. Parkside Financial Bank & Trust lifted its holdings in shares of Maximus by 21.7% during the second quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock valued at $62,000 after purchasing an additional 157 shares during the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Maximus by 60.4% in the 2nd quarter. GAMMA Investing LLC now owns 1,174 shares of the health services provider’s stock worth $82,000 after purchasing an additional 442 shares in the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider Michelle F. Link sold 4,039 shares of the firm’s stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the sale, the insider owned 19,542 shares of the company’s stock, valued at $1,697,027.28. This trade represents a 17.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is currently owned by insiders.

Maximus Stock Performance

MMS stock opened at $86.86 on Wednesday. The stock’s 50 day simple moving average is $84.81 and its 200 day simple moving average is $82.16. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.77. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $92.50. The stock has a market capitalization of $4.73 billion, a PE ratio of 15.62 and a beta of 0.56.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.01). The business had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.34 billion. Maximus had a return on equity of 25.23% and a net margin of 5.87%.The firm’s revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.46 EPS. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. As a group, research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, December 1st. Shareholders of record on Friday, November 14th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, November 14th. This represents a $1.20 annualized dividend and a yield of 1.4%. Maximus’s dividend payout ratio is currently 21.58%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Maximus in a research report on Monday. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, October 27th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Maximus currently has an average rating of “Moderate Buy” and a consensus price target of $90.00.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.